eIF4B is a convergent target and critical effector of oncogenic Pim and PI3K/Akt/mTOR signaling pathways in Abl transformants.
about
miR-150 exerts antileukemia activity in vitro and in vivo through regulating genes in multiple pathwaysUnderstanding of leukemic stem cells and their clinical implications.Hypoxic 3D in vitro culture models reveal distinct resistance processes to TKIs in renal cancer cells.The Roles of microRNAs in Regulating the Expression of PD-1/PD-L1 Immune Checkpoint.PIM Kinases and Their Relevance to the PI3K/AKT/mTOR Pathway in the Regulation of Ovarian Cancer.Preclinical characterization of INCB053914, a novel pan-PIM kinase inhibitor, alone and in combination with anticancer agents, in models of hematologic malignancies.
P2860
eIF4B is a convergent target and critical effector of oncogenic Pim and PI3K/Akt/mTOR signaling pathways in Abl transformants.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
eIF4B is a convergent target a ...... pathways in Abl transformants.
@en
type
label
eIF4B is a convergent target a ...... pathways in Abl transformants.
@en
prefLabel
eIF4B is a convergent target a ...... pathways in Abl transformants.
@en
P2093
P2860
P356
P1433
P1476
eIF4B is a convergent target a ...... pathways in Abl transformants
@en
P2093
Ji-Long Chen
Jianling Yang
Jianning Li
Xuefei Wang
Yuhai Chen
P2860
P304
10073-10089
P356
10.18632/ONCOTARGET.7164
P407
P50
P577
2016-03-01T00:00:00Z